Navigation Links
Edifecs, CAQH and Harvard Pilgrim Health Care Will Examine CORE Phase II Testing Outcomes and Lessons Learned at HIMSS09 Interoperability Showcase
Date:4/4/2009

Harvard Pilgrim achieves CORE Phase II Testing Certification with Edifecs CORE Testing Service - includes compliance with rules that are now required in X12 Version 5010

BELLEVUE, Wash., April 5 /PRNewswire/ -- Edifecs announced today that it will, together with its partners CAQH and Harvard Pilgrim Health Care, examine the outcomes and lessons learned from the CORE Phase II Certification testing including elements of the newly mandated 5010 Rules, in a presentation at the HIMSS09 Interoperability Showcase, on Tuesday, April 7, 11:15 AM - 11:45 AM (CT).

The HIMSS09 Interoperability Showcase has become an internationally recognized forum for highlighting the Integrating the Healthcare Enterprise's (IHE) common framework for delivering interoperability across local, regional, and national health information exchanges. It features advanced technology and standards in an interactive environment using test scenarios that simulate how health information is seamlessly passed across the full continuum of care.

Throughout the conference CAQH CORE and Edifecs will be available (Booth #7750, McCormick Place, North Hall) to demonstrate the Edifecs CORE Testing Service and Harvard Pilgrim will be conducting live transmissions of CORE Phase II Certified Eligibility & Benefits Inquiry and Response 270/271 transactions that incorporate aspects of the 5010 standards. "This collaborative demonstration will showcase how Harvard Pilgrim, being the 1st certified adopter of the CORE Phase II rules, is already realizing benefits from now mandated 5010 standards by using the CORE operating rules. By being the first adopter of the CORE Phase II rules Harvard Pilgrim is producing real-world results that will have a long-term, positive impact on healthcare administration," said Sunny Singh, CEO at Edifecs.

Of equal or possibly greater importance is the fact that the demonstration will be accom
'/>"/>

SOURCE Edifecs, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
3. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
4. Tone Deafness Explained, from the Harvard Health Letter
5. For Most, Good Oral Care Does More Than Antibiotics to Prevent Dental-Related Heart Problems, Reports the Harvard Heart Letter
6. Your Hearing May be at Risk, Says Harvard Mens Health Watch
7. Testosterone May Improve Mental Function, From the Harvard Mens Health Watch
8. Novel PCT Method Unveiled by Pressure BioSciences, Inc. and Collaborators at the Harvard School of Public Health
9. BASF Officially Launches the Collaborative Advanced Research Initiative at Harvard University
10. Harvard Study Shows Folic Acid, B Vitamins in Animi-3(R) May Prevent Vision Loss
11. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...land, Nov. 25 From November 16-18...earing solutions, presented the second edition of ...n the special needs of the older population. The c...g and audiology from around the world and more tha...le with hearing loss for an opportunity to share e...
(Date:11/25/2009)...ov. 25 For many of the m...the 27 million living with untreated hearing loss...diologist Cindy Beyer. ,, Dr. Beyer, senior vic...ca,s largest hearing care and hearing aids compa...ess, frustration, and social isolation, "which can...
(Date:11/25/2009)... 25 Regado Biosciences, a privatel...mbotic aptamers with active control agents, announ... be presenting at the Piper Jaffray 21st Annual He...in New York City. Dr. Mazzo,s presentation will b... will include an overview of the Company,s pipelin...
Breaking Medicine Technology:Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 2Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 3For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 2For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 3Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Sanofi aventis Announces Second Quarter 2009 Results 13244 1Sanofi aventis Announces Second Quarter 2009 Results 13244 2Sanofi aventis Announces Second Quarter 2009 Results 13244 3Sanofi aventis Announces Second Quarter 2009 Results 13244 4Sanofi aventis Announces Second Quarter 2009 Results 13244 5Sanofi aventis Announces Second Quarter 2009 Results 13244 6Sanofi aventis Announces Second Quarter 2009 Results 13244 7Sanofi aventis Announces Second Quarter 2009 Results 13244 8Sanofi aventis Announces Second Quarter 2009 Results 13244 9Sanofi aventis Announces Second Quarter 2009 Results 13244 10Sanofi aventis Announces Second Quarter 2009 Results 13244 11Sanofi aventis Announces Second Quarter 2009 Results 13244 12Sanofi aventis Announces Second Quarter 2009 Results 13244 13Sanofi aventis Announces Second Quarter 2009 Results 13244 14Sanofi aventis Announces Second Quarter 2009 Results 13244 15Sanofi aventis Announces Second Quarter 2009 Results 13244 16Sanofi aventis Announces Second Quarter 2009 Results 13244 17Sanofi aventis Announces Second Quarter 2009 Results 13244 18Sanofi aventis Announces Second Quarter 2009 Results 13244 19Sanofi aventis Announces Second Quarter 2009 Results 13244 20Sanofi aventis Announces Second Quarter 2009 Results 13244 21Sanofi aventis Announces Second Quarter 2009 Results 13244 22Sanofi aventis Announces Second Quarter 2009 Results 13244 23Sanofi aventis Announces Second Quarter 2009 Results 13244 24Sanofi aventis Announces Second Quarter 2009 Results 13244 25Sanofi aventis Announces Second Quarter 2009 Results 13244 26Sanofi aventis Announces Second Quarter 2009 Results 13244 27Patent Awarded for a New X ray Imaging Technology with Capability Unrealized with Present Day Radiological Modalities 13243 1Patent Awarded for a New X ray Imaging Technology with Capability Unrealized with Present Day Radiological Modalities 13243 2New Laser Treatment for Cellulite Helps Fight the Battle 53029 1New Laser Treatment for Cellulite Helps Fight the Battle 53029 2New Laser Treatment for Cellulite Helps Fight the Battle 53029 3
...cent of Patients Showed Complete Response or Reduc...SAN DIEGO, CA, March 05, 2007 /PRNewswire-FirstCal...nnounced the presentation of,positive results from...y of pilot process HspE7, an investigational thera...ted diseases, in women,with the highest grade of c...
...M--(BUSINESS WIRE)--Mar 7, 2007 - BioLineRx Ltd.,(...any, reported,today pre-clinical data from trials ... in preventing deterioration of the myocardium,aft...left ventricle,dilatation and eventual heart failu...rector of the Neufeld Cardiac Research,Institute a...
Other Medicine Technology:Nventa Announces Presentation of Positive HspE7 Data from,NCI-Sponsored Clinical Trial in Cervical Dysplasia 2Nventa Announces Presentation of Positive HspE7 Data from,NCI-Sponsored Clinical Trial in Cervical Dysplasia 3Nventa Announces Presentation of Positive HspE7 Data from,NCI-Sponsored Clinical Trial in Cervical Dysplasia 4Nventa Announces Presentation of Positive HspE7 Data from,NCI-Sponsored Clinical Trial in Cervical Dysplasia 5Nventa Announces Presentation of Positive HspE7 Data from,NCI-Sponsored Clinical Trial in Cervical Dysplasia 6BioLineRx Presents Data on BL-1040 at Cardiovascular,Revascularization Therapies Conference Demonstrating Potential to,Reduce Deterioration of Infarcted Heart Tissue and Maintain,Functionality 2BioLineRx Presents Data on BL-1040 at Cardiovascular,Revascularization Therapies Conference Demonstrating Potential to,Reduce Deterioration of Infarcted Heart Tissue and Maintain,Functionality 3
(Date:11/27/2009)...ealth™ announced today that Spectrum Health ...d Enterprise orthopedic templating solution and it... (PRWEB) November 27, 2009 -- Voyant...h (Grand Rapids, Michigan) has licensed its Trauma...its TraumaCad Extend workflow solution, to allow i...
(Date:11/27/2009)...st manufacturers who use medical load cells at the...llars by bringing in technology partner Flintec ea...ro-active medical manufacturers are calling in Fli...ir projects, ensuring that progress will not be co...lly outdated technology. , ...
(Date:11/26/2009)...ewswire/ -- With cold and flu season upon us, it,s... to control the spread of infections and avoid ill...eep ourselves healthy, but to avoid transmitting i..., CIC (certified in infection-control), nursing di...th at Hospital for Special Surgery (HSS) in Manhat...
(Date:11/26/2009)... of Americans living with diabetes will nearly dou...million in 2034. Over the same period, spending on...lion to $336 billion, even with no increase in the...niversity of Chicago report in the December issue ...iabetes covered by Medicare will rise from 8.2 mil...
(Date:11/26/2009)...y can lead to strains or worse , , THURS...ing wrong with stuffing your turkey full to bursti...th your suitcase as you pack for holiday trips. ,... U.S. hospital emergency rooms, doctors, offices, ...elated injuries, such as muscle strains, pulls and...
Breaking Medicine News(10 mins):Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 4Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Pack Right for the Holidays to Avoid the ER 2
...e used a biochemical chip to explain the important... of yeast cells. The finding could lead to new can...rch team at The John Hopkins University, led by An...has solved a long-standing mystery of how a specif...
... the University at Buffalo and the University of U... aspirin can improve a woman's chances of becoming...// UB's portion of the study is funded by a $... past year. "In women who have had their fi...
... a key signaling protein in the brain during infan...scientists say. //According to findings published ...ptor protein for the chemical messenger serotonin ...for serotonin, a neurotransmitter, show anxiety-li...
...vation therapy may aggravate heart disease in pati...archers at Dana-Farber Cancer Institute. // A...te cancer. The study results were based on d...ate that oncologists should weigh the benefits of ...
...ical doctor who contracted Lassa fever in Nigeria ...a, //the Gauteng Department of Health said on Wedn...ation and is receiving treatment in the hospital's...ent was flown from Abuja in Nigeria on Monday, for...
...at Capital Health are extremely optimistic about t...iew to better management //of emergency care and r...the changes, a plan has been initiated to effectiv...atients who need to be shifted from emergency care...
Other Medicine News:Health News:Biochemical Chip Solves Cell-mating Puzzle 2Health News:Biochemical Chip Solves Cell-mating Puzzle 3Health News:Study to Look at Aspirin as Aid to Conception, Healthy Pregnancy 2Health News:Mouse Study Suggests Anxiety Disorders Take Root in Infancy 2Health News:Benefits of ADT Against Risk of Heart Ailments 2Health News:South Africa: Nigerian Man Treated for Lassa Fever 2
...e Eppendorf Reference Series 2000 Pipette is a syn...mpact and robust design, and superior operating co...to operate the measuring stroke and blow-out as we...ipette/tip" system ensures utmost accuracy and pre...
Pipetman F100
Finnpipette Fixed Volume, 100ul
Ovation BioNatural Pipette, two-stroke, fixed volume, 20L
Medicine Products: